Massachusetts biopharma employment declined in 2025 for the first time in two decades, but the state's VC, IPO, and M&A numbers all ran ahead in the first half of 2026 — a gap that sets up a life-science leasing recovery.
Every weekday · 6:30 a.m. ET
The Morning Brief
The private wealth industry in four minutes, every weekday at 6:30 a.m. ET. Free.